Dr. med. Andreas Wirsching

Department of Medicine 3 – Rheumatology and Immunology

Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells (2026) Rius Rigau AR, Xu M, Liu Z, Chenguiti Fakhouri S, Auth J, Garantziotis P, Zoli A, et al. Journal article Impact of Yoga on Spinal Mobility and Psychological Outcomes in Patients with Axial Spondyloarthritis: A Prospective Non-randomized Controlled Study (2026) Bundle V, Bouzas C, Temiz A, Coppers B, Ebner I, von Alten Blaskowitz PP, Rudolf S, et al. Journal article Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activity (2026) Temiz A, Noversa de Sousa R, Schoen J, Reichardt C, Standfest K, Wirsching A, Hagen M, et al. Journal article BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease (2025) Bucci L, Böltz S, Hagen M, Tur C, Nöthling DM, Rothe T, Wirsching A, et al. Journal article Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus – Authors' reply (2025) Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Düsing C, Krickau T, et al. Journal article BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells (2025) Müller F, Wirsching A, Hagen M, Völkl S, Tur C, Raimondo MG, Taubmann J, et al. Journal article Langzeitverlauf von Effizienz und Sicherheit der CD19-CAR T-Zell-Therapie beim systemischen Lupus erythematodes (2025) Taubmann J, Böltz S, Hagen M, Wirsching A, Müller F, Völkl S, Kharboutli S, et al. Journal article Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus (2025) Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber Bouyer R, Hagen M, et al. Journal article Effects of different B-cell-depleting strategies on the lymphatic tissue (2025) Tur C, Eckstein M, Bucci L, Auth J, Bergmann C, Rauber S, Hagen M, et al. Journal article Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma (2025) Müller F, Schwingen NR, Hagen M, Scholz JK, Aigner M, Wirsching A, Taubmann J, et al. Journal article